475830 — Orum Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Orum Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58,051	12,085	126,658	117,696	132,595
Net Total Accounts Receivable
Net Total Receivables	49.4	106	535	2,738	1,055
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58,535	12,656	127,448	122,510	134,372
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,183	5,184	32,370	30,610	31,014
Long Term Investments
Other Long Term Assets
Total Assets	62,070	21,283	161,783	153,836	169,325
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	716	147,072	194,517	31,864	15,608
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,862	148,744	217,963	32,071	38,437
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	60,208	-127,461	-56,180	121,765	130,888
Total Liabilities & Shareholders' Equity	62,070	21,283	161,783	153,836	169,325
Total Common Shares Outstanding